{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:46:16Z","timestamp":1761630376090},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.transproceed.2004.12.242","type":"journal-article","created":{"date-parts":[[2005,4,21]],"date-time":"2005-04-21T07:40:57Z","timestamp":1114069257000},"page":"682-684","source":"Crossref","is-referenced-by-count":25,"title":["Sirolimus in Pediatric Renal Transplantation"],"prefix":"10.1016","volume":"37","author":[{"given":"J.P.","family":"Ib\u00e1\u00f1ez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Monteverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Turconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2004.12.242_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.12.242_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007890-199907150-00011","article-title":"Neoral monitoring by simplified sparse sampling area under the concentration-time curve: Its relationship to acute rejection and Cyclosporine nephrotoxicity early after kidney transplantation","volume":"68","author":"Mahalati","year":"1999","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2004.12.242_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","article-title":"Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future","volume":"35","author":"De Mattos","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"suppl 75","key":"10.1016\/j.transproceed.2004.12.242_bib4","doi-asserted-by":"crossref","first-page":"S-62","DOI":"10.1046\/j.1523-1755.2000.07502.x","article-title":"Progression of renal damage in chronic rejection","volume":"57","author":"Ponticelli","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2004.12.242_bib5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00007890-200104270-00010","article-title":"Risk factors for post-transplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Cooperative Study (NAPRTCS)","volume":"71","author":"Dharnidharka","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.12.242_bib6","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0041-1345(98)01990-3","article-title":"Lymphoproliferative disease in children","volume":"31","author":"Harmon","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.12.242_bib7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00041552-199511000-00004","article-title":"Rapamycin (sirolimus, rapamune)","volume":"4","author":"Sehgal","year":"1995","journal-title":"Curr Opin Nephrol Hyperten"},{"key":"10.1016\/j.transproceed.2004.12.242_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0009-9120(98)00045-9","article-title":"Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression","volume":"31","author":"Sehgal","year":"1998","journal-title":"Clin Biochem"},{"key":"10.1016\/j.transproceed.2004.12.242_bib9","doi-asserted-by":"crossref","unstructured":"Long-term improvement in renal function with Sirolimus after early Cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune maintenance regimen study. Transplantation 76:364, 2003","DOI":"10.1097\/01.TP.0000074360.62032.39"},{"key":"10.1016\/j.transproceed.2004.12.242_bib10","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/00007890-200210270-00002","article-title":"Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of Sirolimus versus Cyclosporine","volume":"74","author":"Flechner","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.12.242_bib11","doi-asserted-by":"crossref","unstructured":"Sirolimus-based therapy following early Cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. Am J Transplant 4:953, 2004","DOI":"10.1111\/j.1600-6143.2004.00446.x"},{"issue":"suppl 3A","key":"10.1016\/j.transproceed.2004.12.242_bib12","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/S0041-1345(03)00223-9","article-title":"Sirolimus in pediatric transplant recipients","volume":"35","author":"Sindhi","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.12.242_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a Sirolimus\/Cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allograft","volume":"71","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.12.242_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1399-3046.2003.00148.x","article-title":"Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol","volume":"8","author":"Schachter","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2004.12.242_bib15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (Rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with Cyclosporine","volume":"67","author":"Groth","year":"1999","journal-title":"Clin Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134504017002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134504017002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:18:32Z","timestamp":1550189912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134504017002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0041134504017002"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2004.12.242","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}